WATERTOWN, MA—C4 Therapeutics will be relocating its corporate headquarters on West Kendall Street in Cambridge to 45,000 square feet of leased space at the new LINX building here.
The fledgling private biotech firm is the first tenant at Boylston Properties' 185,000-square-foot LINX building at 490 Arsenal St. in Watertown. C4 Therapeutics was founded in late 2015 by Dr. Jay Bradner, along with Ken Anderson, MD, Nathanael Gray PHD, and Marc Cohen. C4 Therapeutics is developing a new class of drugs based on Targeted Protein Degradation to address a broad range of life-threatening and life-impairing diseases. In March of this year, C4 Therapeutics and Calico of San Francisco announced a five-year collaboration to discover, develop and commercialize therapies for treating diseases of aging, including cancer.
The two-story LINX office building was completed in April and C4 Therapeutics will build-out its space at the property and is expected to move to its new headquarters offices by March or April of 2018, according to Duncan Gratton, executive director, Cushman & Wakefield's Greater Boston area , who along with colleague Kate Lien, senior director, represented Boylston Properties in the transaction. C4 Therapeutics was represented by Neil Ross and Tucker Hansen of JLL. C4 Therapeutics currently houses its corporate headquarters at 675 West Kendall St. in Cambridge.
Gratton tells Globest.com that Cushman & Wakefield is in lease discussions with another potential tenant for the LINX building for approximately 18,000 square feet of space. He adds, “We have a lot of leasing momentum and are seeing an increasing number of Cambridge lab and technology companies touring LINX. We expect to be signing additional leases in the near future.”
“The East End of Watertown is the ideal location for C4 Therapeutics,” says Bill McQuillan, president of Boylston Properties. “Not only does the proximity to Boston and Cambridge make the location attractive to technology and life science companies, but the location offers a walkable, urban neighborhood with new housing, retail, restaurants and two new hotels.”
“We are very excited about relocating to the LINX building and to calling Watertown our new home,” states Andy Phillips, CEO of C4 Therapeutics. “LINX is a spectacular work environment that offers us the ideal spot to grow as a company. We like the proximity to other biotechs and we are also thrilled to be part of the vision for growth and rejuvenation in and around Arsenal Yards.”
In April, Boylston Properties announced that a new 145-room Hampton Inn and Suites will be part of the first phase of the redevelopment of the former Arsenal Mall called Arsenal Yards. The new hotel and a garage and about half of the planned retail and restaurants at the development will be part of the first phase of the project. The hotel is scheduled to open in the spring of 2019. Boylston Properties and the Wilder Companies, as well as other partners, are developing the Arsenal Yards project.
When fully built out, Arsenal Yards will feature 350,000 square feet of retail and entertainment space, more than 500 apartments and 100,000 square feet of existing office space.
Want to continue reading?
Become a Free ALM Digital Reader.
Once you are an ALM Digital Member, you’ll receive:
- Breaking commercial real estate news and analysis, on-site and via our newsletters and custom alerts
- Educational webcasts, white papers, and ebooks from industry thought leaders
- Critical coverage of the property casualty insurance and financial advisory markets on our other ALM sites, PropertyCasualty360 and ThinkAdvisor
Already have an account? Sign In Now
*May exclude premium content© 2024 ALM Global, LLC, All Rights Reserved. Request academic re-use from www.copyright.com. All other uses, submit a request to [email protected]. For more information visit Asset & Logo Licensing.
John Jordan
John Jordan is a veteran journalist with 36 years of print and digital media experience.
